Lacticaseibacillus rhamnosus UCO-25A
Lacticaseibacillus rhamnosus UCO-25A is a lactic acid bacterium isolated from human gastric sources. In vitro research has examined the strain's immunomodulatory and antimicrobial properties, with preliminary studies investigating potential mechanisms against specific pathogens. Human clinical evidence remains limited, and efficacy has not been established through rigorous randomized controlled trials.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 3 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
4 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 36979076 →Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?· Biology · 2023